Cantor Fitzgerald Comments on BMRN FY2026 Earnings
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of BioMarin Pharmaceutical in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst O. Brayer anticipates that the biotechnology company will earn $4.29 per share for the […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of BioMarin Pharmaceutical in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst O. Brayer anticipates that the biotechnology company will earn $4.29 per share for the […]
